Your browser doesn't support javascript.
loading
Parents' experiences with sequencing of all known pediatric cancer predisposition genes in children with cancer.
Bon, S B B; Wouters, R H P; Bakhuizen, J J; van den Heuvel-Eibrink, M M; Maurice-Stam, H; Jongmans, M C J; Grootenhuis, M A.
Afiliação
  • Bon SBB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Electronic address: s.b.b.bon@prinsesmaximacentrum.nl.
  • Wouters RHP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Bakhuizen JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Jongmans MCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Genet Med ; : 101250, 2024 Sep 04.
Article em En | MEDLINE | ID: mdl-39244644
ABSTRACT

PURPOSE:

Germline DNA sequencing is increasingly used within pediatric oncology, yet parental experiences remain underexplored.

METHODS:

Parents of children undergoing cancer predisposition gene panel sequencing (143 genes) were surveyed before and after disclosure of results. Questionnaires assessed knowledge, expectations, worries, satisfaction, and regret. Next to descriptives, linear mixed models and generalized mixed models were utilized to explore factors associated with knowledge and worries.

RESULTS:

Out of 325 eligible families, 310 parents (176 mothers and 128 fathers of 188 families) completed all after-consent questionnaires whereas 260 parents (150 mothers and 110 fathers of 181 families) completed all after disclosure questionnaires. Most parents hoped their participation would benefit others, although individual hopes were also common. Sequencing-related worries were common, particularly concerning whether their child would get cancer again, cancer risks for family members and psychosocial implications of testing. Parental satisfaction after disclosure was high and regret scores were low. Lower education was associated with lower knowledge levels, whereas foreign-born parents were at increased risk of experiencing worries.

CONCLUSION:

Germline sequencing of children with cancer is generally well received by their parents. However, careful genetic counseling is essential to ensure that parents are adequately informed and supported throughout the process.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genet Med / Genet. med / Genetics in medicine Assunto da revista: GENETICA MEDICA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genet Med / Genet. med / Genetics in medicine Assunto da revista: GENETICA MEDICA Ano de publicação: 2024 Tipo de documento: Article